SlideShare a Scribd company logo
Dr. ROOPAM JAIN
PROFESSOR & HEAD
INFANCY &
CHILDHOOD
DISORDER
INFANCY & CHILDHOOD DISORDERS
 Congenital anomalies
 Prematurity and fetal growth restriction
 Perinatal infections
 Fetal hydrops
 Inborn errors of metabolism
 Sudden infant death syndrome
 Tumors
Dr. ROOPAM JAIN
Professor & Head
Definition
o SIDS is the sudden, unexplained death of an
infant younger than one year old.
o Some people call SIDS "crib death" because many
babies who die of SIDS are found in their cribs.
INCIDENCE OF
o SIDS is the leading cause of death in children
between one month and one year old.
o Most SIDS deaths occur when babies are between
2 months & 4 months old
o 6000-7000 babies die of SIDS every year in US
 male predominance
 the presence of intrathoracic petechiae
 linked the death to a sleep period (i.e., the time
when the majority of deaths occurred)
PATHOGENESIS
 A leading hypothesis - SIDS may reflect a delay or
abnormality in the development of nerve cells within
the brain that are critical to normal heart and lung
function.
 brainstems of infants who died with a diagnosis of
SIDS have revealed a developmental delay in the
formation and function of several serotonin-binding
nerve cell pathways within the brain.
 The most compelling hypothesis is that SIDS reflects
a delayed development of “arousal” and
cardiorespiratory control
 The serotonergic (5-HT) system of the
medulla is implicated in these “arousal”
responses, as well as regulation of other critical
homeostatic functions such as respiratory drive,
blood pressure & upper airway reflexes
Causes of SIDS ?!
A combination of physical and sleep environmental
factors can make an infant more vulnerable to SIDS.
These factors may vary from child to child.
o Brain abnormalities
o Low birth weight
o Respiratory infection
RISK FACTORS
 A “triple-risk” model of SIDS has been
proposed, which postulates the
intersection of three overlapping factors:
 (1) a vulnerable infant,
 (2) a critical developmental period(first 6 months
of life)
 (3) an exogenous stressor.
Risk Factors with Sudden Infant Death Syndrome
o Sleeping on a soft surface. Lying face down
on a fluffy comforter or a waterbed can block an
infant's airway. Draping a blanket over a baby's
head also is risky.
TUMORS
INFANCY & CHILDHOOD DISORDERS
BENIGN TUMORS
Hemangioma
Lymphatic Tumors
Fibrous Tumors
Teratomas
MALIGNANT TUMORS
Leukemia
Retinoblastoma
Neuroblastoma
Wilms Tumor
Hepatoblastoma
Hepatocellular Carcinoma
Soft Tissue Sarcoma
Others
Common paediatric benign tumours &
tumour-like lesions
Common paediatric malignant tumours
 In infants and children under 4 years of age:
MC malignant tumours are various types of
blastomas.
 Children between 5 to 9 years of age:
haematopoietic malignancies.
 In the age range of 10-14 years:
soft tissue & bony sarcomas.
Common paediatric benign tumours
& tumour-like lesions
Hemangioma
 Hemangioma. Hemangiomas are the most
common tumors of infancy
 In children, most are located in the skin, particularly
on the face and scalp, where they produce flat to
elevated, irregular, red-blue masses; some of the
flat, larger lesions are referred to as port-wine
stains
 Hemangiomas may enlarge along with the growth
of the child, but in many instances they
spontaneously regress
Lymphatic Tumors
 lymphatic origin
 lymphangiomas—are hamartomatous or
neoplastic, whereas others k/s lymphangiectasis.
 The lymphangiomas are usually characterized by
cystic and cavernous spaces.
Teratomas
 Teratomas may occur as benign, well-differentiated cystic
lesions (mature teratomas), immature teratomas, or as
malignant teratomas
 two peaks in incidence: the first at - 2 years of age & the
second in late adolescence or early adulthood
 Sacrococcygeal teratomas are the most common
teratomas of childhood (40%)
 Approximately 75% - mature teratomas
 about 12% - unequivocally malignant and lethal.
 The remainder is immature teratomas;
Sacrococcygeal teratoma
Common paediatric MALIGNENT
tumours
NEUROBLASTOMA
 Neuroblastic tumors include tumors of:
 Sympathetic ganglia
 Adrenal medulla
 These sites have cells derived from
primordial Neural Crest
NEUROBLASTOMA
 Among Neuroblastic tumors, Neuroblastoma is
the most common extracranial solid tumor of
childhood
 It is the most frequently diagnosed tumor of
infancy
 Median age of diagnosis is 18 months & 40% are
diagnosed during infancy
NEUROBLASTOMA
 Germline mutations in Anaplastic Lymphoma
Kinase (ALK) gene is the major cause of familial
predisposition to Neuroblastoma
 40% of cases arise in Adrenal medulla
 Other sites of involvement are:
 Paravertebral region of Abdomen (25%)
 Posterior Mediastinum (15%)
 Rest of the common sites are Pelvis, Neck & within
the Brain (Cerebral Neuroblastoma)
NEUROBLASTOMA
 Morphology (Grossly):
 Size ranges from small nodules (k/s in-situ lesions) to
large masses weighing more than 1 kg.
 In-situ lesions occur more frequently
 majority of which regress leaving only a focus of
fibrosis or calcification in the adult
NEUROBLASTOMA
 Morphology (Grossly):
 Some have fibrous pseudocapsules but others are
infiltrative invading surrounding structures
 On cut section:
 Soft
 Composed of Gray-tan tissue
 May show areas of Hemorrhage and Necrosis
NEUROBLASTOMA
 Morphology (Microscopically):
 Composed of:
 Sheets of small cells with dark nuclei
 Scanty cytoplasm
 Poorly defined cell borders
 Pleomorphism
 Mitotic activity
 Homer-Wright rosettes may be seen
NEUROBLASTOMA
 Clinical progress:
 In children under 2 years of age, Neuroblastoma
presents with large abdominal mass, fever and
weight loss
 In older children, they may not come into attention
until metastasis causing manifestations related to
affected organs such as:
 Bone Pain
 Respiratory Symptoms
 Gastrointestinal Symptoms
WILMS TUMOR
 Also known as Nephroblastoma
 In U.S.A., it is most common primary Renal tumor of
childhood
 Peak incidence is seen in the age group of 2-5 years
 95% cases occur before the age of 10 years
 5-10% cases involve both the kidneys
 Synchronous: If both kidneys affected at same time
 Metachronous: If affected one after another
WILMS TUMOR
 The exact cause of Wilms tumor is not clear but in rare cases,
heredity plays a role
 Risk factors:
 African-American race
 Family history of Wilms tumor
 Some cases can occur as a part of three syndromes:
 WAGR Syndrome
 Denys-Drash Syndrome
 Beckwith-Wiedemann Syndrome
WILMS TUMOR
 WAGR Syndrome:
 It includes Wilms tumor, Aniridia, Genitourinary system
abnormalities and Mental Retardation
 These cases carry germline deletion of chromosome 11p13
 This chromosome carry the first Wilms Tumor associated
gene WT1
 The lifetime chances of occurrence of Wilms tumor is 33%
WILMS TUMOR
 Denys-Drash Syndrome:
 It includes gonadal dysgenesis and early onset nephropathy
 These cases also carry germline abnormalities in WT1 which
affects DNA binding properties
 These cases have higher risk of Wilms tumor (~90%)
WILMS TUMOR
 Beckwith-Wiedemann Syndrome:
 This is clinically different from both WAGR & Denys-Drash
syndromes but this also has high risk of developing Wilms
Tumor
 This syndrome is characterized by enlargement of body
organs, macroglossia, ear abnormalities & abnormal large
cells in Adrenal Cortex
 The chromosome region implicated has been localized to
band 11p15.5 and termed as WT2
WILMS TUMOR
 Morphology:
 Grossly:
 Tumor is large, solitary and well circumscribed
 10% cases are bilateral or multicentric
 On cut section,
• Soft
• Homogenous
• Tan to gray in color
• Occasionally foci of hemorrhage and necrosis
seen
Wilms tumor in the lower pole of the
kidney with the characteristic tan-to-gray
color & well-circumscribed margins
WILMS TUMOR
 Morphology:
 microscopically:
 Tumor is composed of sheets of small blue cells
 5% cases show features of anaplasia i.e. Presence of
cells with nuclei features:
• Large
• Hyperchromatic
• Pleomorphic
• With mitotic figures
Focal anaplasia was present in this Wilms tumor
in other areas, characterized by cells with
hyperchromatic, pleomorphic nuclei, and
abnormal mitoses.
WILMS TUMOR
 Clinical features:
 Large abdominal mass which may extend to pelvis
 Hematuria
 Abdominal pain
 Intestinal obstruction
 In some cases, pulmonary metastasis is present at
the time of primary diagnosis
Dr. ROOPAM JAIN
PROFESSOR & HEAD
Environmental &
Nutritional Diseases
Alarming environmental degradation
 1. Population explosion
 2. Urbanisation of rural & forest land to
accommodate the increasing numbers
 3. Accumulation of wastes
 4. Unsatisfactory disposal of radioactive and
electronic waste
 5. Industrial effluents and automobile exhausts
Environmental &
nutritional diseases
1. Environmental pollution:
 i. Air pollution
 ii. Environmental chemicals
 iii. Tobacco smoking
2. Chemical and drug injury:
 i. Therapeutic (iatrogenic) drug injury
 ii. Non-therapeutic toxic agents (e.g. alcohol, lead,
carbon monoxide, drug abuse)
 iii. Environmental chemicals
3. Injury by physical agents:
 i. Thermal and electrical injury
 ii. Injury by ionising radiation
4. Nutritional diseases:
 i. Overnutrition (obesity)
 ii. Undernutrition (starvation, PEM, vitamin
deficiencies).
ENVIRONMENTAL POLLUTION
 Any agent— chemical, physical or microbial, that
alters the composition of environment is called
pollutant
 air pollution,
 environmental chemicals
 tobacco smoking.
AIR POLLUTION
 The adverse effects of air pollutants on lung depend
upon a few variables that include:
 i) longer duration of exposure;
 ii) total dose of exposure;
 iii) impaired ability of the host to clear inhaled particles;
 iv) particle size of 1-5 µm capable of getting impacted in
the distal airways to produce tissue injury.
ENVIRONMENTAL CHEMICALS
 1. Agriculture chemicals
 2. Volatile organic solvents
 3. Metals Pollution by occupational exposure to
toxic metals such as mercury, arsenic, cadmium,
iron, nickel & aluminium are important hazardous
environmental chemicals.
 4. Aromatic hydrocarbons - are contaminant in
several preservatives, herbicides and antibacterial
agents are a chronic health hazard.
 5. Cyanide- released by combustion of plastic, silk
 6. Environmental dusts
TOBACCO SMOKING
The relative risk of major diseases in tobacco
smokers compared from non-smokers
 i) Cancer of the lung: 12 to 23 times
 ii) COPD: 10-13 times
 iii) Cancers of upper aerodigestive tract (larynx,
pharynx, lip, oral cavity, oesophagus): 6 to 14 times
 iv) Aortic aneurysm: 6-7 times
 v) Other cancers by systemic effects (kidneys,
pancreas, urinary bladder, stomach, cervix): 2-3
times
 vi) Cerebrovascular accidents (CVA): 2-4 times
 vii) Coronary heart disease: 2 to 3 times relative risk
 viii) Sudden infant death syndrome: 2 times
 ix) Buerger’s disease (thromboangiitis obliterans)
 x) Peptic ulcer disease AC 70%higher risk in smokers.
 xi) Early menopause in smoker women.
 xii) In smoking pregnant women, higher risk of LBW
of foetus, higher perinatal mortality and intellectual
deterioration of newborn.
Major constituents of tobacco
smoke with adverse effects
Major adverse effects of tobacco smoking
Summary of the adverse effects of smoking
CHEMICAL AND DRUG INJURY
 1. Therapeutic (iatrogenic) agents e.g.
drugs, which when administered indiscriminately
are associated with adverse effects.
 2. Non-therapeutic agents e.g. alcohol, lead,
carbon monoxide, drug abuse.
CHEMICAL AND DRUG INJURY
THERAPEUTIC (IATROGENIC) DRUG INJURY
Adverse effects of drugs may appear due to:
 i) overdose;
 ii) genetic predisposition;
 iii) exaggerated pharmacologic response
 iv) interaction with other drugs
 v) unknown factors.
Iatrogenic drug injury
Iatrogenic drug injury
Iatrogenic drug injury
Iatrogenic drug injury
Adverse drug reaction.
Skin pigmentation caused by minocycline
(a long-acting tetracycline derivative)
Diffuse blue-gray pigmentation of the forearm
NON-THERAPEUTIC TOXIC AGENTS
1. ALCOHOLISM
 most of the alcohol-related injury to different
organs is due to toxic effects of alcohol and
accumulation of its main toxic metabolite,
acetaldehyde, in the blood.
 Other proposed mechanisms of tissue injury in
chronic alcoholism are free-radical mediated
injury and genetic susceptibility to alcohol-
dependence & tissue damage.
NON-THERAPEUTIC TOXIC AGENTS
1. ALCOHOLISM
Metabolism of ethanol in the liver
Complications of chronic alcoholism
NON-THERAPEUTIC TOXIC AGENTS
2. LEAD POISONING
 Lead poisoning may occur in children or adults
due to accidental or occupational ingestion.
 absorbed lead is distributed in two types of
tissues
 a) Bones, teeth, nails and hair b) Brain, liver,
kidneys and bone marrow
Complications of
lead poisoning
NON-THERAPEUTIC TOXIC AGENTS
3. CARBON MONOXIDE POISONING
 CO poisoning may present in 2 ways:
 Acute CO poisoning in which there is sudden
development of brain hypoxia characterised by
oedema and petechial haemorrhages.
 Chronic CO poisoning presents with nonspecific
changes of slowly developing hypoxia of the brain.
INJURY BY RADIATION
 most important form of radiation injury is ionising
radiation which has three types of effects on cells:
 i) Somatic effects which cause acute cell killing.
 ii) Genetic damage by mutations and therefore,
passes genetic defects in the next progeny of cells.
 iii) Malignant transformation of cells
 1. Skin: radiation dermatitis, cancer.
 2. Lungs: interstitial pulmonary fibrosis.
 3. Heart: myocardial fibrosis, constrictive pericarditis.
 4. Kidney: radiation nephritis.
 5. GI tract: strictures of small bowel and oesophagus.
 6 Gonads: testicular atrophy & destruction of ovaries.
 7. Haematopoietic tissue: pancytopenia due to bone
marrow depression.
 8. Eyes: cataract.
4. DRUG ABUSE
 use of certain drugs for the purpose of ‘mood alteration’ or
‘euphoria’ or ‘kick’ but subsequently leading to habit-
forming, dependence & eventually addiction
 1. Marijuana or ‘pot’ is psychoactive substance – (leaves
of the plant Cannabis sativa) (contains
tetrahydrocannabinol ) (smoked or ingested.
 2. Derivatives of opium (heroin and morphine). Opioids
are derived from the poppy plant.
 3. CNS depressants - barbiturates, tranquilisers, alcohol.
 4. CNS stimulants e.g. cocaine and amphetamines.
 5. Psychedelic drugs e.g. LSD.
 6. lnhalants e.g. glue, paint thinner, nail polish remover,
aerosols, amyl nitrite.
Common Drugs of Abuse
Common Drugs of Abuse
The effect of cocaine on neurotransmission
The drug inhibits reuptake of the
neurotransmitters dopamine & norepinephrine
in the CNS & PNS
INFANCY & CHILDHOOD DISORDER

More Related Content

What's hot

Leukocytosis. Leukopenia. Leukosis
Leukocytosis. Leukopenia. LeukosisLeukocytosis. Leukopenia. Leukosis
Leukocytosis. Leukopenia. Leukosis
Ivano-Frankivsk National Medical University
 
nephritic and nephrotic syndrome
   nephritic and nephrotic syndrome   nephritic and nephrotic syndrome
nephritic and nephrotic syndrome
jaynandanprasadsah2
 
disseminated intravascular coagulation
disseminated intravascular coagulationdisseminated intravascular coagulation
disseminated intravascular coagulation
Krishna Vasudev
 
Red Blood cell pathology
Red Blood cell pathologyRed Blood cell pathology
Red Blood cell pathology
Ganapathy Tamilselvan
 
Iron overload
Iron overloadIron overload
Iron overload
Niveen Daoud
 
Hemodynamic disorders
Hemodynamic disorders Hemodynamic disorders
Hemodynamic disorders
Muhammadasif909
 
Thrombosis & embolism
Thrombosis & embolismThrombosis & embolism
Thrombosis & embolism
University of Sydney
 
May Hegglin Anomaly
May Hegglin AnomalyMay Hegglin Anomaly
May Hegglin Anomaly
Prof. Ahmed Mohamed Badheeb
 
Lec 24 24 female reproductive system pathology
Lec 24 24 female reproductive system pathologyLec 24 24 female reproductive system pathology
Lec 24 24 female reproductive system pathology
imrana tanvir
 
Dystrophy
DystrophyDystrophy
Pathology of Endocrine Disorders
Pathology of Endocrine DisordersPathology of Endocrine Disorders
Pathology of Endocrine Disorders
Shashidhar Venkatesh Murthy
 
Thrombosis , embolism & Infraction
Thrombosis , embolism & InfractionThrombosis , embolism & Infraction
Thrombosis , embolism & Infraction
Aadhya Medicure Pathlabs Vijayanagar colony.hyderabad
 
Approach to patient with platelet disorders
Approach to patient with platelet disordersApproach to patient with platelet disorders
Approach to patient with platelet disorders
Chetan Ganteppanavar
 
Cell injury : Intracellular accumulations
Cell injury : Intracellular accumulationsCell injury : Intracellular accumulations
Cell injury : Intracellular accumulations
Vijay Shankar
 
How to approach a child with bleeding disorder
How to approach a child with bleeding disorderHow to approach a child with bleeding disorder
How to approach a child with bleeding disorderKamran Akbar
 
hemoglobinopathies
hemoglobinopathieshemoglobinopathies
hemoglobinopathies
Kriti Kriti
 
Acute and chronic inflammation 1 robbins
Acute and chronic inflammation 1  robbinsAcute and chronic inflammation 1  robbins
Acute and chronic inflammation 1 robbinssujiiss
 
Jaundice
JaundiceJaundice
Jaundice
Vincent Ribaya
 

What's hot (20)

Leukocytosis. Leukopenia. Leukosis
Leukocytosis. Leukopenia. LeukosisLeukocytosis. Leukopenia. Leukosis
Leukocytosis. Leukopenia. Leukosis
 
nephritic and nephrotic syndrome
   nephritic and nephrotic syndrome   nephritic and nephrotic syndrome
nephritic and nephrotic syndrome
 
Lect.no(6)
Lect.no(6)Lect.no(6)
Lect.no(6)
 
disseminated intravascular coagulation
disseminated intravascular coagulationdisseminated intravascular coagulation
disseminated intravascular coagulation
 
Red Blood cell pathology
Red Blood cell pathologyRed Blood cell pathology
Red Blood cell pathology
 
Iron overload
Iron overloadIron overload
Iron overload
 
Hemodynamic disorders
Hemodynamic disorders Hemodynamic disorders
Hemodynamic disorders
 
Thrombosis & embolism
Thrombosis & embolismThrombosis & embolism
Thrombosis & embolism
 
Leukemia
LeukemiaLeukemia
Leukemia
 
May Hegglin Anomaly
May Hegglin AnomalyMay Hegglin Anomaly
May Hegglin Anomaly
 
Lec 24 24 female reproductive system pathology
Lec 24 24 female reproductive system pathologyLec 24 24 female reproductive system pathology
Lec 24 24 female reproductive system pathology
 
Dystrophy
DystrophyDystrophy
Dystrophy
 
Pathology of Endocrine Disorders
Pathology of Endocrine DisordersPathology of Endocrine Disorders
Pathology of Endocrine Disorders
 
Thrombosis , embolism & Infraction
Thrombosis , embolism & InfractionThrombosis , embolism & Infraction
Thrombosis , embolism & Infraction
 
Approach to patient with platelet disorders
Approach to patient with platelet disordersApproach to patient with platelet disorders
Approach to patient with platelet disorders
 
Cell injury : Intracellular accumulations
Cell injury : Intracellular accumulationsCell injury : Intracellular accumulations
Cell injury : Intracellular accumulations
 
How to approach a child with bleeding disorder
How to approach a child with bleeding disorderHow to approach a child with bleeding disorder
How to approach a child with bleeding disorder
 
hemoglobinopathies
hemoglobinopathieshemoglobinopathies
hemoglobinopathies
 
Acute and chronic inflammation 1 robbins
Acute and chronic inflammation 1  robbinsAcute and chronic inflammation 1  robbins
Acute and chronic inflammation 1 robbins
 
Jaundice
JaundiceJaundice
Jaundice
 

Similar to INFANCY & CHILDHOOD DISORDER

INFANCY & CHILDHOOD TUMOR
INFANCY & CHILDHOOD TUMORINFANCY & CHILDHOOD TUMOR
INFANCY & CHILDHOOD TUMOR
Dr. Roopam Jain
 
Embryonal brain tumours in children
Embryonal brain tumours in childrenEmbryonal brain tumours in children
Embryonal brain tumours in children
Appy Akshay Agarwal
 
Embryonal Brain tumours in children
Embryonal Brain tumours in childrenEmbryonal Brain tumours in children
Embryonal Brain tumours in children
Evith Pereira
 
Cancer in Children - Denise Sheer
Cancer in Children - Denise SheerCancer in Children - Denise Sheer
Cancer in Children - Denise SheerDenise Sheer
 
2brain tumors.pptx
2brain tumors.pptx2brain tumors.pptx
2brain tumors.pptx
Adesh Shrivastava
 
I LOVE NEUROSURGERY INITIATIVE: INTRACRANIAL TUMORS.ppt
I LOVE NEUROSURGERY INITIATIVE: INTRACRANIAL TUMORS.pptI LOVE NEUROSURGERY INITIATIVE: INTRACRANIAL TUMORS.ppt
I LOVE NEUROSURGERY INITIATIVE: INTRACRANIAL TUMORS.ppt
walid maani
 
Tumours of the head & neck in the childhood
Tumours of the head & neck in the childhoodTumours of the head & neck in the childhood
Tumours of the head & neck in the childhoodShekhar Krishna Debnath
 
Childhood cancer / Oncological diseases in Pediatric groups
Childhood cancer / Oncological diseases in Pediatric groupsChildhood cancer / Oncological diseases in Pediatric groups
Childhood cancer / Oncological diseases in Pediatric groups
Monisha Sekar
 
Childhood tumours
Childhood tumoursChildhood tumours
Childhood tumours
Jamiu Bello
 
Wilms tumour an overview
Wilms tumour an overviewWilms tumour an overview
Wilms tumour an overview
pharmaindexing
 
-brain-tumors-100719051022-phpapp02.pptx
-brain-tumors-100719051022-phpapp02.pptx-brain-tumors-100719051022-phpapp02.pptx
-brain-tumors-100719051022-phpapp02.pptx
Bakr8
 
Neuroblastoma and nephroblastoma
Neuroblastoma and nephroblastoma Neuroblastoma and nephroblastoma
Neuroblastoma and nephroblastoma
Sackler's faculty of medicine . Tel-Aviv.Uni
 
CNS TUMORS.ppt
CNS TUMORS.pptCNS TUMORS.ppt
CNS TUMORS.ppt
LarissaSams1
 
Brain Tumors
Brain TumorsBrain Tumors
Brain Tumors
Drhardik Patel
 
5_6188103624975976363.pptx
5_6188103624975976363.pptx5_6188103624975976363.pptx
5_6188103624975976363.pptx
KalpitThakore
 
DISEASES OF GENETIC MUTATION, TREATMENTS(2).pptx
DISEASES OF GENETIC MUTATION, TREATMENTS(2).pptxDISEASES OF GENETIC MUTATION, TREATMENTS(2).pptx
DISEASES OF GENETIC MUTATION, TREATMENTS(2).pptx
Tasiumujahid
 
Brain tumours
Brain tumoursBrain tumours
NEPHROBLASTOMA.pptx
NEPHROBLASTOMA.pptxNEPHROBLASTOMA.pptx
NEPHROBLASTOMA.pptx
PendoC1
 
Pediatric oncology (2).pdf
Pediatric oncology (2).pdfPediatric oncology (2).pdf
Pediatric oncology (2).pdf
Sunanda Bhowmik
 
Pediatric Supratentorial Tumors / Tumores Supratentoriais Pediátrico
Pediatric Supratentorial Tumors / Tumores Supratentoriais PediátricoPediatric Supratentorial Tumors / Tumores Supratentoriais Pediátrico
Pediatric Supratentorial Tumors / Tumores Supratentoriais Pediátrico
Erion Junior de Andrade
 

Similar to INFANCY & CHILDHOOD DISORDER (20)

INFANCY & CHILDHOOD TUMOR
INFANCY & CHILDHOOD TUMORINFANCY & CHILDHOOD TUMOR
INFANCY & CHILDHOOD TUMOR
 
Embryonal brain tumours in children
Embryonal brain tumours in childrenEmbryonal brain tumours in children
Embryonal brain tumours in children
 
Embryonal Brain tumours in children
Embryonal Brain tumours in childrenEmbryonal Brain tumours in children
Embryonal Brain tumours in children
 
Cancer in Children - Denise Sheer
Cancer in Children - Denise SheerCancer in Children - Denise Sheer
Cancer in Children - Denise Sheer
 
2brain tumors.pptx
2brain tumors.pptx2brain tumors.pptx
2brain tumors.pptx
 
I LOVE NEUROSURGERY INITIATIVE: INTRACRANIAL TUMORS.ppt
I LOVE NEUROSURGERY INITIATIVE: INTRACRANIAL TUMORS.pptI LOVE NEUROSURGERY INITIATIVE: INTRACRANIAL TUMORS.ppt
I LOVE NEUROSURGERY INITIATIVE: INTRACRANIAL TUMORS.ppt
 
Tumours of the head & neck in the childhood
Tumours of the head & neck in the childhoodTumours of the head & neck in the childhood
Tumours of the head & neck in the childhood
 
Childhood cancer / Oncological diseases in Pediatric groups
Childhood cancer / Oncological diseases in Pediatric groupsChildhood cancer / Oncological diseases in Pediatric groups
Childhood cancer / Oncological diseases in Pediatric groups
 
Childhood tumours
Childhood tumoursChildhood tumours
Childhood tumours
 
Wilms tumour an overview
Wilms tumour an overviewWilms tumour an overview
Wilms tumour an overview
 
-brain-tumors-100719051022-phpapp02.pptx
-brain-tumors-100719051022-phpapp02.pptx-brain-tumors-100719051022-phpapp02.pptx
-brain-tumors-100719051022-phpapp02.pptx
 
Neuroblastoma and nephroblastoma
Neuroblastoma and nephroblastoma Neuroblastoma and nephroblastoma
Neuroblastoma and nephroblastoma
 
CNS TUMORS.ppt
CNS TUMORS.pptCNS TUMORS.ppt
CNS TUMORS.ppt
 
Brain Tumors
Brain TumorsBrain Tumors
Brain Tumors
 
5_6188103624975976363.pptx
5_6188103624975976363.pptx5_6188103624975976363.pptx
5_6188103624975976363.pptx
 
DISEASES OF GENETIC MUTATION, TREATMENTS(2).pptx
DISEASES OF GENETIC MUTATION, TREATMENTS(2).pptxDISEASES OF GENETIC MUTATION, TREATMENTS(2).pptx
DISEASES OF GENETIC MUTATION, TREATMENTS(2).pptx
 
Brain tumours
Brain tumoursBrain tumours
Brain tumours
 
NEPHROBLASTOMA.pptx
NEPHROBLASTOMA.pptxNEPHROBLASTOMA.pptx
NEPHROBLASTOMA.pptx
 
Pediatric oncology (2).pdf
Pediatric oncology (2).pdfPediatric oncology (2).pdf
Pediatric oncology (2).pdf
 
Pediatric Supratentorial Tumors / Tumores Supratentoriais Pediátrico
Pediatric Supratentorial Tumors / Tumores Supratentoriais PediátricoPediatric Supratentorial Tumors / Tumores Supratentoriais Pediátrico
Pediatric Supratentorial Tumors / Tumores Supratentoriais Pediátrico
 

More from Dr. Roopam Jain

NECROSIS & APOTOSIS by Dr. Roopam Jain
NECROSIS & APOTOSIS by Dr. Roopam JainNECROSIS & APOTOSIS by Dr. Roopam Jain
NECROSIS & APOTOSIS by Dr. Roopam Jain
Dr. Roopam Jain
 
Morphology of Cell injury by Dr. Roopam Jain
Morphology of Cell injury by Dr. Roopam JainMorphology of Cell injury by Dr. Roopam Jain
Morphology of Cell injury by Dr. Roopam Jain
Dr. Roopam Jain
 
Pathogenesis of Cell Injury
Pathogenesis of Cell InjuryPathogenesis of Cell Injury
Pathogenesis of Cell Injury
Dr. Roopam Jain
 
CELL INJURY-2 by DR. ROOPAM JAIN
CELL INJURY-2 by DR. ROOPAM JAINCELL INJURY-2 by DR. ROOPAM JAIN
CELL INJURY-2 by DR. ROOPAM JAIN
Dr. Roopam Jain
 
USMLE Style case based study & MCQs Neoplasia
USMLE Style case based study & MCQs Neoplasia USMLE Style case based study & MCQs Neoplasia
USMLE Style case based study & MCQs Neoplasia
Dr. Roopam Jain
 
CELL INJURY, CELLULAR ADAPTATION by DR. ROOPAM JAIN
CELL INJURY, CELLULAR ADAPTATION by DR. ROOPAM JAINCELL INJURY, CELLULAR ADAPTATION by DR. ROOPAM JAIN
CELL INJURY, CELLULAR ADAPTATION by DR. ROOPAM JAIN
Dr. Roopam Jain
 
Introduction of pathology by DR. ROOPAM JAIN
Introduction of pathology by DR. ROOPAM JAINIntroduction of pathology by DR. ROOPAM JAIN
Introduction of pathology by DR. ROOPAM JAIN
Dr. Roopam Jain
 
NEOPLASIA MCQs & USMLE Style case based study by Dr. ROOPAM JAIN
NEOPLASIA MCQs & USMLE Style case based study by Dr. ROOPAM JAINNEOPLASIA MCQs & USMLE Style case based study by Dr. ROOPAM JAIN
NEOPLASIA MCQs & USMLE Style case based study by Dr. ROOPAM JAIN
Dr. Roopam Jain
 
MCQs Hemodynamic Disorders, Thromboembolic Disease & Shock by DR. ROOPAM JAIN
MCQs Hemodynamic Disorders, Thromboembolic Disease & Shock by DR. ROOPAM JAINMCQs Hemodynamic Disorders, Thromboembolic Disease & Shock by DR. ROOPAM JAIN
MCQs Hemodynamic Disorders, Thromboembolic Disease & Shock by DR. ROOPAM JAIN
Dr. Roopam Jain
 
INFECTIOUS DISEASES by DR. ROOPAM JAIN for NEET PG
INFECTIOUS DISEASES by DR. ROOPAM JAIN for NEET PGINFECTIOUS DISEASES by DR. ROOPAM JAIN for NEET PG
INFECTIOUS DISEASES by DR. ROOPAM JAIN for NEET PG
Dr. Roopam Jain
 
INFECTIOUS DISEASE (Diseases caused by bacteria, spirochaetes, mycobacteria &...
INFECTIOUS DISEASE (Diseases caused by bacteria, spirochaetes, mycobacteria &...INFECTIOUS DISEASE (Diseases caused by bacteria, spirochaetes, mycobacteria &...
INFECTIOUS DISEASE (Diseases caused by bacteria, spirochaetes, mycobacteria &...
Dr. Roopam Jain
 
Diseases caused by Bacteria, Spirochaetes & Mycobacteria BY Dr. ROOPAM JAIN
Diseases caused by Bacteria, Spirochaetes & Mycobacteria BY Dr. ROOPAM JAINDiseases caused by Bacteria, Spirochaetes & Mycobacteria BY Dr. ROOPAM JAIN
Diseases caused by Bacteria, Spirochaetes & Mycobacteria BY Dr. ROOPAM JAIN
Dr. Roopam Jain
 
INFECTIOUS DISEASE by DR. ROOPAM JAIN
INFECTIOUS DISEASE by DR. ROOPAM JAININFECTIOUS DISEASE by DR. ROOPAM JAIN
INFECTIOUS DISEASE by DR. ROOPAM JAIN
Dr. Roopam Jain
 
INFECTIOUS DISEASE - Human Viruses & Viral Diseases by Dr. Roopam Jain
INFECTIOUS DISEASE - Human Viruses & Viral Diseases by Dr. Roopam JainINFECTIOUS DISEASE - Human Viruses & Viral Diseases by Dr. Roopam Jain
INFECTIOUS DISEASE - Human Viruses & Viral Diseases by Dr. Roopam Jain
Dr. Roopam Jain
 
DISEASES CAUSED BY FUNGI
DISEASES CAUSED BY FUNGIDISEASES CAUSED BY FUNGI
DISEASES CAUSED BY FUNGI
Dr. Roopam Jain
 
Hemodynamic disorders - Edema, Hyperemia, Hemorrahge by DR. ROOPAM JAIN
Hemodynamic disorders - Edema, Hyperemia, Hemorrahge by DR. ROOPAM JAINHemodynamic disorders - Edema, Hyperemia, Hemorrahge by DR. ROOPAM JAIN
Hemodynamic disorders - Edema, Hyperemia, Hemorrahge by DR. ROOPAM JAIN
Dr. Roopam Jain
 
EMBOLISM -1
EMBOLISM -1EMBOLISM -1
EMBOLISM -1
Dr. Roopam Jain
 
Hemodynamic Disorders, Thromboembolic Disease & Shock-HYPERCOAGULABLE STATES ...
Hemodynamic Disorders, Thromboembolic Disease & Shock-HYPERCOAGULABLE STATES ...Hemodynamic Disorders, Thromboembolic Disease & Shock-HYPERCOAGULABLE STATES ...
Hemodynamic Disorders, Thromboembolic Disease & Shock-HYPERCOAGULABLE STATES ...
Dr. Roopam Jain
 
HYPERAEMIA & CONGESTION
HYPERAEMIA & CONGESTIONHYPERAEMIA & CONGESTION
HYPERAEMIA & CONGESTION
Dr. Roopam Jain
 
Derangements of Homeostasis & Haemodynamics
Derangements of Homeostasis & HaemodynamicsDerangements of Homeostasis & Haemodynamics
Derangements of Homeostasis & Haemodynamics
Dr. Roopam Jain
 

More from Dr. Roopam Jain (20)

NECROSIS & APOTOSIS by Dr. Roopam Jain
NECROSIS & APOTOSIS by Dr. Roopam JainNECROSIS & APOTOSIS by Dr. Roopam Jain
NECROSIS & APOTOSIS by Dr. Roopam Jain
 
Morphology of Cell injury by Dr. Roopam Jain
Morphology of Cell injury by Dr. Roopam JainMorphology of Cell injury by Dr. Roopam Jain
Morphology of Cell injury by Dr. Roopam Jain
 
Pathogenesis of Cell Injury
Pathogenesis of Cell InjuryPathogenesis of Cell Injury
Pathogenesis of Cell Injury
 
CELL INJURY-2 by DR. ROOPAM JAIN
CELL INJURY-2 by DR. ROOPAM JAINCELL INJURY-2 by DR. ROOPAM JAIN
CELL INJURY-2 by DR. ROOPAM JAIN
 
USMLE Style case based study & MCQs Neoplasia
USMLE Style case based study & MCQs Neoplasia USMLE Style case based study & MCQs Neoplasia
USMLE Style case based study & MCQs Neoplasia
 
CELL INJURY, CELLULAR ADAPTATION by DR. ROOPAM JAIN
CELL INJURY, CELLULAR ADAPTATION by DR. ROOPAM JAINCELL INJURY, CELLULAR ADAPTATION by DR. ROOPAM JAIN
CELL INJURY, CELLULAR ADAPTATION by DR. ROOPAM JAIN
 
Introduction of pathology by DR. ROOPAM JAIN
Introduction of pathology by DR. ROOPAM JAINIntroduction of pathology by DR. ROOPAM JAIN
Introduction of pathology by DR. ROOPAM JAIN
 
NEOPLASIA MCQs & USMLE Style case based study by Dr. ROOPAM JAIN
NEOPLASIA MCQs & USMLE Style case based study by Dr. ROOPAM JAINNEOPLASIA MCQs & USMLE Style case based study by Dr. ROOPAM JAIN
NEOPLASIA MCQs & USMLE Style case based study by Dr. ROOPAM JAIN
 
MCQs Hemodynamic Disorders, Thromboembolic Disease & Shock by DR. ROOPAM JAIN
MCQs Hemodynamic Disorders, Thromboembolic Disease & Shock by DR. ROOPAM JAINMCQs Hemodynamic Disorders, Thromboembolic Disease & Shock by DR. ROOPAM JAIN
MCQs Hemodynamic Disorders, Thromboembolic Disease & Shock by DR. ROOPAM JAIN
 
INFECTIOUS DISEASES by DR. ROOPAM JAIN for NEET PG
INFECTIOUS DISEASES by DR. ROOPAM JAIN for NEET PGINFECTIOUS DISEASES by DR. ROOPAM JAIN for NEET PG
INFECTIOUS DISEASES by DR. ROOPAM JAIN for NEET PG
 
INFECTIOUS DISEASE (Diseases caused by bacteria, spirochaetes, mycobacteria &...
INFECTIOUS DISEASE (Diseases caused by bacteria, spirochaetes, mycobacteria &...INFECTIOUS DISEASE (Diseases caused by bacteria, spirochaetes, mycobacteria &...
INFECTIOUS DISEASE (Diseases caused by bacteria, spirochaetes, mycobacteria &...
 
Diseases caused by Bacteria, Spirochaetes & Mycobacteria BY Dr. ROOPAM JAIN
Diseases caused by Bacteria, Spirochaetes & Mycobacteria BY Dr. ROOPAM JAINDiseases caused by Bacteria, Spirochaetes & Mycobacteria BY Dr. ROOPAM JAIN
Diseases caused by Bacteria, Spirochaetes & Mycobacteria BY Dr. ROOPAM JAIN
 
INFECTIOUS DISEASE by DR. ROOPAM JAIN
INFECTIOUS DISEASE by DR. ROOPAM JAININFECTIOUS DISEASE by DR. ROOPAM JAIN
INFECTIOUS DISEASE by DR. ROOPAM JAIN
 
INFECTIOUS DISEASE - Human Viruses & Viral Diseases by Dr. Roopam Jain
INFECTIOUS DISEASE - Human Viruses & Viral Diseases by Dr. Roopam JainINFECTIOUS DISEASE - Human Viruses & Viral Diseases by Dr. Roopam Jain
INFECTIOUS DISEASE - Human Viruses & Viral Diseases by Dr. Roopam Jain
 
DISEASES CAUSED BY FUNGI
DISEASES CAUSED BY FUNGIDISEASES CAUSED BY FUNGI
DISEASES CAUSED BY FUNGI
 
Hemodynamic disorders - Edema, Hyperemia, Hemorrahge by DR. ROOPAM JAIN
Hemodynamic disorders - Edema, Hyperemia, Hemorrahge by DR. ROOPAM JAINHemodynamic disorders - Edema, Hyperemia, Hemorrahge by DR. ROOPAM JAIN
Hemodynamic disorders - Edema, Hyperemia, Hemorrahge by DR. ROOPAM JAIN
 
EMBOLISM -1
EMBOLISM -1EMBOLISM -1
EMBOLISM -1
 
Hemodynamic Disorders, Thromboembolic Disease & Shock-HYPERCOAGULABLE STATES ...
Hemodynamic Disorders, Thromboembolic Disease & Shock-HYPERCOAGULABLE STATES ...Hemodynamic Disorders, Thromboembolic Disease & Shock-HYPERCOAGULABLE STATES ...
Hemodynamic Disorders, Thromboembolic Disease & Shock-HYPERCOAGULABLE STATES ...
 
HYPERAEMIA & CONGESTION
HYPERAEMIA & CONGESTIONHYPERAEMIA & CONGESTION
HYPERAEMIA & CONGESTION
 
Derangements of Homeostasis & Haemodynamics
Derangements of Homeostasis & HaemodynamicsDerangements of Homeostasis & Haemodynamics
Derangements of Homeostasis & Haemodynamics
 

Recently uploaded

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 

Recently uploaded (20)

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 

INFANCY & CHILDHOOD DISORDER

  • 1. Dr. ROOPAM JAIN PROFESSOR & HEAD INFANCY & CHILDHOOD DISORDER
  • 2. INFANCY & CHILDHOOD DISORDERS  Congenital anomalies  Prematurity and fetal growth restriction  Perinatal infections  Fetal hydrops  Inborn errors of metabolism  Sudden infant death syndrome  Tumors
  • 4. Definition o SIDS is the sudden, unexplained death of an infant younger than one year old. o Some people call SIDS "crib death" because many babies who die of SIDS are found in their cribs.
  • 5. INCIDENCE OF o SIDS is the leading cause of death in children between one month and one year old. o Most SIDS deaths occur when babies are between 2 months & 4 months old o 6000-7000 babies die of SIDS every year in US  male predominance  the presence of intrathoracic petechiae  linked the death to a sleep period (i.e., the time when the majority of deaths occurred)
  • 6. PATHOGENESIS  A leading hypothesis - SIDS may reflect a delay or abnormality in the development of nerve cells within the brain that are critical to normal heart and lung function.  brainstems of infants who died with a diagnosis of SIDS have revealed a developmental delay in the formation and function of several serotonin-binding nerve cell pathways within the brain.  The most compelling hypothesis is that SIDS reflects a delayed development of “arousal” and cardiorespiratory control
  • 7.  The serotonergic (5-HT) system of the medulla is implicated in these “arousal” responses, as well as regulation of other critical homeostatic functions such as respiratory drive, blood pressure & upper airway reflexes
  • 8. Causes of SIDS ?! A combination of physical and sleep environmental factors can make an infant more vulnerable to SIDS. These factors may vary from child to child. o Brain abnormalities o Low birth weight o Respiratory infection
  • 9. RISK FACTORS  A “triple-risk” model of SIDS has been proposed, which postulates the intersection of three overlapping factors:  (1) a vulnerable infant,  (2) a critical developmental period(first 6 months of life)  (3) an exogenous stressor.
  • 10.
  • 11. Risk Factors with Sudden Infant Death Syndrome
  • 12.
  • 13.
  • 14. o Sleeping on a soft surface. Lying face down on a fluffy comforter or a waterbed can block an infant's airway. Draping a blanket over a baby's head also is risky.
  • 16. BENIGN TUMORS Hemangioma Lymphatic Tumors Fibrous Tumors Teratomas MALIGNANT TUMORS Leukemia Retinoblastoma Neuroblastoma Wilms Tumor Hepatoblastoma Hepatocellular Carcinoma Soft Tissue Sarcoma Others
  • 17. Common paediatric benign tumours & tumour-like lesions
  • 19.  In infants and children under 4 years of age: MC malignant tumours are various types of blastomas.  Children between 5 to 9 years of age: haematopoietic malignancies.  In the age range of 10-14 years: soft tissue & bony sarcomas.
  • 20. Common paediatric benign tumours & tumour-like lesions
  • 21. Hemangioma  Hemangioma. Hemangiomas are the most common tumors of infancy  In children, most are located in the skin, particularly on the face and scalp, where they produce flat to elevated, irregular, red-blue masses; some of the flat, larger lesions are referred to as port-wine stains  Hemangiomas may enlarge along with the growth of the child, but in many instances they spontaneously regress
  • 22. Lymphatic Tumors  lymphatic origin  lymphangiomas—are hamartomatous or neoplastic, whereas others k/s lymphangiectasis.  The lymphangiomas are usually characterized by cystic and cavernous spaces.
  • 23. Teratomas  Teratomas may occur as benign, well-differentiated cystic lesions (mature teratomas), immature teratomas, or as malignant teratomas  two peaks in incidence: the first at - 2 years of age & the second in late adolescence or early adulthood  Sacrococcygeal teratomas are the most common teratomas of childhood (40%)  Approximately 75% - mature teratomas  about 12% - unequivocally malignant and lethal.  The remainder is immature teratomas;
  • 26.
  • 27. NEUROBLASTOMA  Neuroblastic tumors include tumors of:  Sympathetic ganglia  Adrenal medulla  These sites have cells derived from primordial Neural Crest
  • 28. NEUROBLASTOMA  Among Neuroblastic tumors, Neuroblastoma is the most common extracranial solid tumor of childhood  It is the most frequently diagnosed tumor of infancy  Median age of diagnosis is 18 months & 40% are diagnosed during infancy
  • 29. NEUROBLASTOMA  Germline mutations in Anaplastic Lymphoma Kinase (ALK) gene is the major cause of familial predisposition to Neuroblastoma  40% of cases arise in Adrenal medulla  Other sites of involvement are:  Paravertebral region of Abdomen (25%)  Posterior Mediastinum (15%)  Rest of the common sites are Pelvis, Neck & within the Brain (Cerebral Neuroblastoma)
  • 30. NEUROBLASTOMA  Morphology (Grossly):  Size ranges from small nodules (k/s in-situ lesions) to large masses weighing more than 1 kg.  In-situ lesions occur more frequently  majority of which regress leaving only a focus of fibrosis or calcification in the adult
  • 31. NEUROBLASTOMA  Morphology (Grossly):  Some have fibrous pseudocapsules but others are infiltrative invading surrounding structures  On cut section:  Soft  Composed of Gray-tan tissue  May show areas of Hemorrhage and Necrosis
  • 32.
  • 33. NEUROBLASTOMA  Morphology (Microscopically):  Composed of:  Sheets of small cells with dark nuclei  Scanty cytoplasm  Poorly defined cell borders  Pleomorphism  Mitotic activity  Homer-Wright rosettes may be seen
  • 34.
  • 35. NEUROBLASTOMA  Clinical progress:  In children under 2 years of age, Neuroblastoma presents with large abdominal mass, fever and weight loss  In older children, they may not come into attention until metastasis causing manifestations related to affected organs such as:  Bone Pain  Respiratory Symptoms  Gastrointestinal Symptoms
  • 36.
  • 37. WILMS TUMOR  Also known as Nephroblastoma  In U.S.A., it is most common primary Renal tumor of childhood  Peak incidence is seen in the age group of 2-5 years  95% cases occur before the age of 10 years  5-10% cases involve both the kidneys  Synchronous: If both kidneys affected at same time  Metachronous: If affected one after another
  • 38. WILMS TUMOR  The exact cause of Wilms tumor is not clear but in rare cases, heredity plays a role  Risk factors:  African-American race  Family history of Wilms tumor  Some cases can occur as a part of three syndromes:  WAGR Syndrome  Denys-Drash Syndrome  Beckwith-Wiedemann Syndrome
  • 39. WILMS TUMOR  WAGR Syndrome:  It includes Wilms tumor, Aniridia, Genitourinary system abnormalities and Mental Retardation  These cases carry germline deletion of chromosome 11p13  This chromosome carry the first Wilms Tumor associated gene WT1  The lifetime chances of occurrence of Wilms tumor is 33%
  • 40. WILMS TUMOR  Denys-Drash Syndrome:  It includes gonadal dysgenesis and early onset nephropathy  These cases also carry germline abnormalities in WT1 which affects DNA binding properties  These cases have higher risk of Wilms tumor (~90%)
  • 41. WILMS TUMOR  Beckwith-Wiedemann Syndrome:  This is clinically different from both WAGR & Denys-Drash syndromes but this also has high risk of developing Wilms Tumor  This syndrome is characterized by enlargement of body organs, macroglossia, ear abnormalities & abnormal large cells in Adrenal Cortex  The chromosome region implicated has been localized to band 11p15.5 and termed as WT2
  • 42. WILMS TUMOR  Morphology:  Grossly:  Tumor is large, solitary and well circumscribed  10% cases are bilateral or multicentric  On cut section, • Soft • Homogenous • Tan to gray in color • Occasionally foci of hemorrhage and necrosis seen
  • 43. Wilms tumor in the lower pole of the kidney with the characteristic tan-to-gray color & well-circumscribed margins
  • 44. WILMS TUMOR  Morphology:  microscopically:  Tumor is composed of sheets of small blue cells  5% cases show features of anaplasia i.e. Presence of cells with nuclei features: • Large • Hyperchromatic • Pleomorphic • With mitotic figures
  • 45. Focal anaplasia was present in this Wilms tumor in other areas, characterized by cells with hyperchromatic, pleomorphic nuclei, and abnormal mitoses.
  • 46. WILMS TUMOR  Clinical features:  Large abdominal mass which may extend to pelvis  Hematuria  Abdominal pain  Intestinal obstruction  In some cases, pulmonary metastasis is present at the time of primary diagnosis
  • 47. Dr. ROOPAM JAIN PROFESSOR & HEAD Environmental & Nutritional Diseases
  • 48. Alarming environmental degradation  1. Population explosion  2. Urbanisation of rural & forest land to accommodate the increasing numbers  3. Accumulation of wastes  4. Unsatisfactory disposal of radioactive and electronic waste  5. Industrial effluents and automobile exhausts
  • 49. Environmental & nutritional diseases 1. Environmental pollution:  i. Air pollution  ii. Environmental chemicals  iii. Tobacco smoking 2. Chemical and drug injury:  i. Therapeutic (iatrogenic) drug injury  ii. Non-therapeutic toxic agents (e.g. alcohol, lead, carbon monoxide, drug abuse)  iii. Environmental chemicals
  • 50. 3. Injury by physical agents:  i. Thermal and electrical injury  ii. Injury by ionising radiation 4. Nutritional diseases:  i. Overnutrition (obesity)  ii. Undernutrition (starvation, PEM, vitamin deficiencies).
  • 51. ENVIRONMENTAL POLLUTION  Any agent— chemical, physical or microbial, that alters the composition of environment is called pollutant  air pollution,  environmental chemicals  tobacco smoking.
  • 52. AIR POLLUTION  The adverse effects of air pollutants on lung depend upon a few variables that include:  i) longer duration of exposure;  ii) total dose of exposure;  iii) impaired ability of the host to clear inhaled particles;  iv) particle size of 1-5 µm capable of getting impacted in the distal airways to produce tissue injury.
  • 53. ENVIRONMENTAL CHEMICALS  1. Agriculture chemicals  2. Volatile organic solvents  3. Metals Pollution by occupational exposure to toxic metals such as mercury, arsenic, cadmium, iron, nickel & aluminium are important hazardous environmental chemicals.  4. Aromatic hydrocarbons - are contaminant in several preservatives, herbicides and antibacterial agents are a chronic health hazard.  5. Cyanide- released by combustion of plastic, silk  6. Environmental dusts
  • 54. TOBACCO SMOKING The relative risk of major diseases in tobacco smokers compared from non-smokers  i) Cancer of the lung: 12 to 23 times  ii) COPD: 10-13 times  iii) Cancers of upper aerodigestive tract (larynx, pharynx, lip, oral cavity, oesophagus): 6 to 14 times  iv) Aortic aneurysm: 6-7 times  v) Other cancers by systemic effects (kidneys, pancreas, urinary bladder, stomach, cervix): 2-3 times
  • 55.  vi) Cerebrovascular accidents (CVA): 2-4 times  vii) Coronary heart disease: 2 to 3 times relative risk  viii) Sudden infant death syndrome: 2 times  ix) Buerger’s disease (thromboangiitis obliterans)  x) Peptic ulcer disease AC 70%higher risk in smokers.  xi) Early menopause in smoker women.  xii) In smoking pregnant women, higher risk of LBW of foetus, higher perinatal mortality and intellectual deterioration of newborn.
  • 56. Major constituents of tobacco smoke with adverse effects
  • 57. Major adverse effects of tobacco smoking
  • 58. Summary of the adverse effects of smoking
  • 59. CHEMICAL AND DRUG INJURY  1. Therapeutic (iatrogenic) agents e.g. drugs, which when administered indiscriminately are associated with adverse effects.  2. Non-therapeutic agents e.g. alcohol, lead, carbon monoxide, drug abuse.
  • 60. CHEMICAL AND DRUG INJURY THERAPEUTIC (IATROGENIC) DRUG INJURY Adverse effects of drugs may appear due to:  i) overdose;  ii) genetic predisposition;  iii) exaggerated pharmacologic response  iv) interaction with other drugs  v) unknown factors.
  • 62.
  • 66. Adverse drug reaction. Skin pigmentation caused by minocycline (a long-acting tetracycline derivative) Diffuse blue-gray pigmentation of the forearm
  • 67. NON-THERAPEUTIC TOXIC AGENTS 1. ALCOHOLISM  most of the alcohol-related injury to different organs is due to toxic effects of alcohol and accumulation of its main toxic metabolite, acetaldehyde, in the blood.  Other proposed mechanisms of tissue injury in chronic alcoholism are free-radical mediated injury and genetic susceptibility to alcohol- dependence & tissue damage.
  • 68. NON-THERAPEUTIC TOXIC AGENTS 1. ALCOHOLISM Metabolism of ethanol in the liver
  • 70. NON-THERAPEUTIC TOXIC AGENTS 2. LEAD POISONING  Lead poisoning may occur in children or adults due to accidental or occupational ingestion.  absorbed lead is distributed in two types of tissues  a) Bones, teeth, nails and hair b) Brain, liver, kidneys and bone marrow
  • 72. NON-THERAPEUTIC TOXIC AGENTS 3. CARBON MONOXIDE POISONING  CO poisoning may present in 2 ways:  Acute CO poisoning in which there is sudden development of brain hypoxia characterised by oedema and petechial haemorrhages.  Chronic CO poisoning presents with nonspecific changes of slowly developing hypoxia of the brain.
  • 73. INJURY BY RADIATION  most important form of radiation injury is ionising radiation which has three types of effects on cells:  i) Somatic effects which cause acute cell killing.  ii) Genetic damage by mutations and therefore, passes genetic defects in the next progeny of cells.  iii) Malignant transformation of cells
  • 74.  1. Skin: radiation dermatitis, cancer.  2. Lungs: interstitial pulmonary fibrosis.  3. Heart: myocardial fibrosis, constrictive pericarditis.  4. Kidney: radiation nephritis.  5. GI tract: strictures of small bowel and oesophagus.  6 Gonads: testicular atrophy & destruction of ovaries.  7. Haematopoietic tissue: pancytopenia due to bone marrow depression.  8. Eyes: cataract.
  • 75. 4. DRUG ABUSE  use of certain drugs for the purpose of ‘mood alteration’ or ‘euphoria’ or ‘kick’ but subsequently leading to habit- forming, dependence & eventually addiction  1. Marijuana or ‘pot’ is psychoactive substance – (leaves of the plant Cannabis sativa) (contains tetrahydrocannabinol ) (smoked or ingested.  2. Derivatives of opium (heroin and morphine). Opioids are derived from the poppy plant.  3. CNS depressants - barbiturates, tranquilisers, alcohol.  4. CNS stimulants e.g. cocaine and amphetamines.  5. Psychedelic drugs e.g. LSD.  6. lnhalants e.g. glue, paint thinner, nail polish remover, aerosols, amyl nitrite.
  • 78. The effect of cocaine on neurotransmission The drug inhibits reuptake of the neurotransmitters dopamine & norepinephrine in the CNS & PNS